NRx Pharmaceuticals furnishes investor presentation with no material new details

NRX Pharmaceuticals, Inc.

Furnished updated investor presentation for meetings starting Sept 8, 2026.
Presentation may be used in future investor and analyst meetings with modifications.
No financial or operational specifics disclosed in the 8-K body.
Exhibit content not available; no material changes to operations reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.